238
Participants
Start Date
April 1, 2018
Primary Completion Date
December 31, 2024
Study Completion Date
December 31, 2024
Sugammadex
Reversal of deep NMB
Neostigmine
Reversal of moderate NMB
Campus Bio-medico, Roma
Campus Bio-Medico University
OTHER